KLK3 and prostate cancer: Since it has been shown that the incidence of clinically significant prostate cancer (csPCa) in PI-RADS 3 lesions may be as high as 25%, the biopsy decision of this patient group relies on additional clinical factors such as digital rectal examination, age, tumor volume, and prostate-specific antigen (PSA) density [6,7].